An integrated method for optimized identification of effective natural inhibitors against SARS-CoV-2 3CLpro

Sci Rep. 2021 Nov 23;11(1):22796. doi: 10.1038/s41598-021-02266-3.

Abstract

The current severe situation of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has not been reversed and posed great threats to global health. Therefore, there is an urgent need to find out effective antiviral drugs. The 3-chymotrypsin-like protease (3CLpro) in SARS-CoV-2 serve as a promising anti-virus target due to its essential role in the regulation of virus reproduction. Here, we report an improved integrated approach to identify effective 3CLpro inhibitors from effective Chinese herbal formulas. With this approach, we identified the 5 natural products (NPs) including narcissoside, kaempferol-3-O-gentiobioside, rutin, vicenin-2 and isoschaftoside as potential anti-SARS-CoV-2 candidates. Subsequent molecular dynamics simulation additionally revealed that these molecules can be tightly bound to 3CLpro and confirmed effectiveness against COVID-19. Moreover, kaempferol-3-o-gentiobioside, vicenin-2 and isoschaftoside were first reported to have SARS-CoV-2 3CLpro inhibitory activity. In summary, this optimized integrated strategy for drug screening can be utilized in the discovery of antiviral drugs to achieve rapid acquisition of drugs with specific effects on antiviral targets.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / analysis*
  • Biological Products / analysis
  • Biological Products / pharmacology
  • COVID-19 / metabolism
  • COVID-19 Drug Treatment
  • Computational Biology / methods
  • Coronavirus 3C Proteases / drug effects
  • Coronavirus 3C Proteases / metabolism
  • Drug Discovery / methods
  • Drug Evaluation, Preclinical / methods*
  • Flavonols / metabolism
  • Flavonols / pharmacology
  • Humans
  • Molecular Docking Simulation
  • Molecular Dynamics Simulation
  • SARS-CoV-2 / drug effects*
  • SARS-CoV-2 / metabolism
  • SARS-CoV-2 / pathogenicity

Substances

  • Antiviral Agents
  • Biological Products
  • Flavonols
  • Coronavirus 3C Proteases